Eli Lilly CEO’s pay grows—again—to $23.7M after COVID antibody launch, new approvals

The COVID-19 pandemic derailed plans for companies worldwide last year, but Eli Lilly adapted by developing medicines against the novel coronavirus—to the tune of $ 871 million in antibody revenue for Q4—while still pushing sales of its newer meds. Now, CEO David Ricks is reaping the rewards with a pay package that could place him… Read More »

India’s Covid vaccine maker told to meet domestic demand first, urges ‘rest of the world’ to be patient

An AstraZeneca vaccine production line. Bloomberg | Bloomberg | Getty Images The world’s largest vaccine maker by volume, Serum Institute of India, has been told to meet domestic demand for Covid-19 shots first — before distributing them overseas. The move implies that foreign governments could face order delays from the company as it places India’s… Read More »